Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0V9OL
|
||||
| Former ID |
DIB000631
|
||||
| Drug Name |
534U87
|
||||
| Synonyms |
Anticonvulsant, Glaxo Wellcome; BW-534U87
|
||||
| Indication | Epileptic seizures [ICD9: 345.9, 780.3; ICD10:G40, P90, R56] | Discontinued in Phase 2 | [546089] | ||
| Company |
Burroughs Wellcome Inc
|
||||
| CAS Number |
CAS 133563-45-8
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Modulator | [525627] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.